Breakthrough Medical Study Reveals ProSense® Efficacy in Pain Relief
Significant Findings in Abdominal Wall Endometriosis Treatment
Recent independent studies demonstrate that patients undergoing ProSense® cryoablation procedures experienced a remarkable decline in pain. Specifically, the median pain score dropped from 8, on a scale of 0-10, to an impressive median of 0. These results highlight the effectiveness of ProSense® in addressing a challenging medical condition.
Understanding ProSense® and Its Approval
ProSense® is an innovative cryoablation technology that has successfully received FDA clearance and is approved across the European Union for various gynecological conditions. This advanced system provides a novel approach to treatment by utilizing liquid nitrogen to precisely freeze and destroy painful lesions associated with endometriosis.
The Challenges of Abdominal Wall Endometriosis
Abdominal wall endometriosis (AWE) can severely affect individuals, particularly those with surgical scars from past cesarean sections. Symptoms of AWE include cyclical pain and the presence of palpable masses. Traditional treatment options like hormonal therapy and invasive surgeries often fall short, sparking interest in alternatives like cryoablation.
Exciting Results from the Study
A recent peer-reviewed study published in the Journal of Personalized Medicine sheds light on the efficacy and safety of personalized percutaneous single-probe liquid-nitrogen cryoablation using ProSense®. This significant research involved 14 patients with a total of 23 lesions treated effectively. The results indicated substantial pain relief and high procedural efficacy.
Key Highlights from the Study
The study yielded several noteworthy outcomes:
- Substantial Pain Relief: Median pain scores fell to 0/10 at a 3-month follow-up (p < 0.0001).
- High Procedural Efficacy: MRI confirmed complete coverage of the ablation zone, with no hemorrhagic inclusions present.
- Streamlined Procedure: Median ablation times were recorded at 15 minutes, with total procedural duration averaging 93 minutes.
- Safe and Excellent Cosmetic Outcomes: No complications were reported, and there were no visible scars.
- Low Retreatment Rate: Only 14% of patients required a second treatment, both achieving satisfactory results.
Endometriosis: A Global Health Concern
According to the World Health Organization, endometriosis is a chronic condition affecting approximately 10% of women during their reproductive years globally. This condition can lead to debilitating symptoms that heavily impact daily life, making effective treatment solutions crucial.
About the Innovative ProSense® Technology
ProSense® utilizes cutting-edge cryoablation methods to ensure minimally invasive tumor destruction. It harnesses liquid nitrogen to create extensive lethal zones, maximizing the efficacy of tumor removal, whether benign or malignant. This technology plays a pivotal role in treating various types of tumors, including those found in the breast, kidney, lung, and liver.
The Benefits of ProSense®
The ProSense® system enhances the treatment experience by accelerating recovery times, minimizing pain, and reducing the risks associated with traditional surgery. Its compact and transportable nature ensures that office-based procedures can be performed quickly and conveniently.
Company Background: IceCure Medical
IceCure Medical (NASDAQ: ICCM) is dedicated to pioneering advanced cryoablation therapy systems aimed at tumor destruction. Their primary focus lie in treating cancers of the breast, kidney, bone, and lung. With a commitment to scalability and safety, IceCure Medical continues to develop innovative alternatives that allow for effective tumor removal procedures without the need for invasive surgery.
Frequently Asked Questions
1. What is ProSense®?
ProSense® is a cryoablation technology that freezes tumors for effective removal, offering a minimally invasive treatment option.
2. How effective is ProSense® for abdominal wall endometriosis?
Clinical studies indicate significant pain relief and high procedural efficacy with ProSense®, with pain scores dropping from 8 to 0 post-treatment.
3. What complications are associated with ProSense® cryoablation?
No complications were reported in recent studies, and patients did not experience visible scarring.
4. How long does the ProSense® procedure take?
The median ablation time is approximately 15 minutes, and the overall procedure typically lasts about 93 minutes.
5. Which conditions can ProSense® treat?
ProSense® is effective for a variety of tumors, including those associated with breast, kidney, lung, and other cancers.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.